Century Therapeutics, Inc. Form 8-K Summary
Business Context and Reporting Period
Century Therapeutics, Inc., a Delaware corporation and emerging growth company, filed this Current Report on Form 8-K on January 12, 2026. The company is headquartered in Philadelphia, Pennsylvania, and its common stock trades on the Nasdaq Capital Market under the symbol "IPSC."
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document serves solely to disclose an update to an investor presentation.
Material Changes
The primary event reported is the update of information reflected in a slide presentation (Exhibit 99.1) dated January 12, 2026. Management intends to use this updated presentation in various meetings with investors. No material changes to financial performance or operational status are detailed within the text of this report.
Guidance, Outlook, and Risks
The filing explicitly states that the information contained herein, including the attached investor presentation, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed "incorporated by reference" into any other filing unless expressly set forth by specific reference. Consequently, no formal guidance, outlook, or risk factors are established by this specific document.
Key Facts for Investor Verification
- Verify the content of the updated investor presentation attached as Exhibit 99.1, as the 8-K text only references its existence.
- Confirm that the updated presentation is not legally incorporated by reference into other SEC filings unless explicitly stated elsewhere.
- Note that the company is classified as an emerging growth company.
- Check subsequent filings for actual financial data, as this report contains no quantitative metrics.